Package 0069-6323-30

{"route": ["ORAL"], "spl_id": "1ce17020-050b-4fdc-8201-1a5648ca8a66", "openfda": {"upc": ["0300692150305", "0300692250302", "0300692170303", "0300692160304", "0300692190301", "0300696565303", "0300696747303", "0300697810303", "0300692270300", "0300697232303", "0300697476301", "0300696180308", "0300696323309", "0300692260301", "0300697654303"], "unii": ["48A5M73Z4Q", "864V2Q084H"], "rxcui": ["404011", "404013", "597967", "597977", "597980", "597984", "597987", "597990", "750199", "750203", "750207", "750211", "750227", "750231", "750235", "750239"], "spl_set_id": ["6f1a9bd8-ee30-4c7d-932f-3fa8c4e087b6"], "manufacturer_name": ["Pfizer Laboratories Div Pfizer Inc"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (0069-6323-30)", "package_ndc": "0069-6323-30", "marketing_start_date": "20220831"}], "brand_name": "Caduet", "product_id": "0069-6323_1ce17020-050b-4fdc-8201-1a5648ca8a66", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]", "HMG-CoA Reductase Inhibitor [EPC]", "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "product_ndc": "0069-6323", "generic_name": "amlodipine and atorvastatin", "labeler_name": "Pfizer Laboratories Div Pfizer Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Caduet", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "5 mg/1"}, {"name": "ATORVASTATIN CALCIUM TRIHYDRATE", "strength": "20 mg/1"}], "application_number": "NDA021540", "marketing_category": "NDA", "marketing_start_date": "20220831", "listing_expiration_date": "20261231"}